Combinatorial docking and combinatorial chemistry: Design of potent non-peptide thrombin inhibitors

被引:0
|
作者
Hans-Joachim Böhm
David W. Banner
Lutz Weber
机构
[1] Hoffmann-La Roche Ltd,Pharmaceuticals Division
来源
Journal of Computer-Aided Molecular Design | 1999年 / 13卷
关键词
combinatorial; de novo design; docking; scoring functions; thrombin;
D O I
暂无
中图分类号
学科分类号
摘要
A computational algorithm was used to design automatically novel thrombin inhibitors that are available from a single-step chemical reaction. The compounds do not contain amide bonds, are achiral and have a molecular weight below 400. Of the 10 compounds that were synthesized, five bind to thrombin with a Ki in the nanomolar range. Subsequent X-ray structure determination of the thrombin-inhibitor complex for the best compound (Ki=95 nM) confirms the predicted binding mode. The novel algorithm is applicable to a broad range of chemical reactions.
引用
收藏
页码:51 / 56
页数:5
相关论文
共 50 条
  • [1] Combinatorial docking and combinatorial chemistry:: Design of potent non-peptide thrombin inhibitors
    Böhm, HJ
    Banner, DW
    Weber, L
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1999, 13 (01) : 51 - 56
  • [2] De novo design of potent non-peptide thrombin inhibitors
    Bohm, HJ
    Banner, DW
    Weber, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U689 - U689
  • [3] A novel series of potent, non-peptide active site thrombin inhibitors
    Lu, T
    Soll, R
    Tomczuk, B
    Illig, C
    Subasinghe, N
    Bone, R
    Locke, K
    Harrison, R
    Spurlino, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1178 - U1178
  • [4] A novel series of potent, non-peptide active-site thrombin inhibitors
    Lu, T
    Soll, R
    Tomczuk, B
    Illig, C
    Subasinghe, N
    Bone, R
    Locke, K
    Harrison, R
    Spurlino, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 185 - MEDI
  • [5] Design, synthesis and antithrombotic evaluation of novel non-peptide thrombin inhibitors
    Chen, Dongxing
    Shi, Jinyu
    Liu, Jing
    Zhang, Xueying
    Deng, Xiaoying
    Yang, Yanyan
    Cui, Shuang
    Zhu, Qihua
    Gong, Guoqing
    Xu, Yungen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (02) : 458 - 470
  • [6] POTENT, BIOAVAILABLE THROMBIN INHIBITORS: DRUG CANDIDATES FROM STRUCTURE BASED DRUG DESIGN, COMBINATORIAL CHEMISTRY AND CHEMI-INFORMATICS
    Spurlino, John C.
    Salemme, F. Raymond
    McMillan, Martin
    Bone, Roger
    Soll, Richard M.
    Tomczuk, Bruce
    Lu, Tianbao
    Illig, Carl R.
    Murphy, Larry
    Radzicka, Anna
    Randle, Troy
    Eisennagel, Stephen
    Lewandowski, Frank
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 151 - 151
  • [7] From peptide to non-peptide metalloconstructs: Dynamic combinatorial libraries of oxorhenium coordinates for the selection of new cyclophilin inhibitors
    Clavaud, Cecile
    Le Gal, Julien
    Thai, Robert
    Heckenroth, Marion
    Stricane, Charlotte
    Lelait, Marie-Anne
    Moutiez, Mireille
    Dugave, Christophe
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 16 - 16
  • [8] Discovery of potent, non-peptide thrombin receptor antagonists.
    Chackalamannil, S
    Xia, Y
    Clasby, M
    Greenlee, W
    Doller, D
    Eagen, K
    Tsai, HS
    Asberom, T
    Lin, Y
    Czarniecki, M
    Ahn, HS
    Foster, C
    Boykow, G
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U60 - U60
  • [9] Design and synthesis of non-peptide Ras CAAX mimetics as potent farnesyltransferase inhibitors
    Qian, YM
    Vogt, A
    Sebti, SM
    Hamilton, AD
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 217 - 223
  • [10] Design and synthesis of potent, non-peptide inhibitors of HCVNS3 protease
    Zhang, XJ
    Schmitt, AC
    Jiang, W
    Wasserman, Z
    Decicco, CP
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1157 - 1160